查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1972093

心臟輔助設備市場：2026-2032年全球預測（按產品類型、適應症、供應模式、最終用戶、應用和通路）

Cardiac Assist Devices & Equipment Market by Product Type, Indication, Delivery Mode, End User, Application, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，心臟輔助設備市場價值將達到 19.4 億美元，到 2026 年將成長至 20.8 億美元，到 2032 年將達到 33.2 億美元，複合年成長率為 7.96%。

主要市場統計數據
基準年 2025 19.4億美元
預計年份：2026年 20.8億美元
預測年份 2032 33.2億美元
複合年成長率 (%) 7.96%

在急性和慢性心血管護理路徑中，將心臟輔助裝置的戰略重要性置於臨床發展和運作壓力的背景下進行定位。

引言部分闡述了心臟支持裝置及相關設備在現代心血管治療中的應用範圍和關鍵意義。過去十年間，技術進步、臨床路徑的變革以及患者人群結構的變化，使得心室支持裝置、主動脈內球囊反搏泵、導管式心室支持裝置和體外膜肺氧合（ECMO）等裝置成為生命維持的核心。臨床醫生和醫療系統領導者如今不僅將這些技術視為救命措施，更將其視為貫穿急性期穩定、過渡策略和長期循環支持的綜合治療路徑的重要組成部分。

設備設計、微創輸送方法、數位遙測和混合護理路徑的創新如何重塑臨床醫生的實踐和供應商的差異化。

心臟輔助裝置領域正經歷一場變革，其驅動力來自於裝置設計、手術方法和臨床證據的創新。連續流心室輔助裝置正從小眾的救命工具發展成更持久的臨終治療方案。同時，基於導管的心室輔助系統在縮短手術時間和擴大高風險經皮治療的應用範圍方面取得了顯著進展。這些技術進步與體外膜氧合（ECMO）技術的進步相輔相成，ECMO強調便攜性、氧合效率和簡化的抗凝血策略，從而加速了其適應症的擴展和臨床應用。

因應不斷變化的關稅政策所帶來的連鎖反應：加強供應鏈韌性、在地化和降低採購風險的策略。

到2025年，關稅政策調整和貿易措施的累積影響，給依賴跨境供應鏈生產心臟輔助設備和耗材的製造商、經銷商和醫療保健系統帶來了新的挑戰。關稅相關的成本壓力進一步凸顯了本地生產、區域供應合約和庫存最佳化策略的重要性，這些策略有助於降低到岸成本和採購前置作業時間波動的影響。在此背景下，採購團隊被迫重新評估供應商選擇，並專注於供應的連續性和合約保障，以應對關稅波動和海關相關的延誤。

產品架構、臨床應用、醫療保健環境、治療方法和通路方面的細微細分如何影響差異化的商業和臨床策略？

細分市場分析揭示了產品類型、醫療環境、臨床應用、適應症、給藥方式和分銷管道如何獨特地影響整個價值鏈中的技術採納和服務需求。在產品類型中，存在著種類繁多的設備，從在高風險介入治療期間提供短期循環支持的導管式心室輔助系統，到作為重症監護支持平台的體外膜肺氧合（ECMO）系統。主動脈內球囊反搏幫浦仍是血流動力學穩定的戰術性支援工具。同時，心室輔助裝置分為連續流和脈動流兩種類型，可處理各種慢性及急性循環衰竭病例。連續流平台進一步細分為左心室輔助裝置、右心室輔助裝置和雙心室輔助裝置，每種裝置都有其獨特的植入複雜性、追蹤需求和臨床結果特徵。

管理體制、臨床能力和報銷優先事項方面的區域差異決定了全球市場的引進管道和商業化策略。

區域趨勢對醫療器材的設計重點、監理合規路徑和商業推廣策略有顯著影響。在美洲，重點在於與三級醫療網路合作、建立健全的先進療法報銷機制，以及需要以療效主導的證據來支持醫療器材的長期應用。在該地區，領先的醫療中心和高運轉率的三級醫院在製定臨床通訊協定和建立培訓模式方面發揮核心作用，這種影響力會向下輻射到規模較小的醫院和專科心臟中心。

競爭優勢由模組化技術平台、整合服務模式和臨床夥伴關係關係所構成。

心臟輔助設備領域的競爭格局由技術差異化、全生命週期服務以及與臨床機構的策略合作共同塑造。領先的製造商正投資於模組化平台，以方便升級並與監測生態系統互通性；而新參與企業則專注於小眾價值提案，例如設備便攜性、簡化的抗凝血方案，或將技術與培訓和遠端支援相結合的服務型經營模式。

為製造商和醫療保健系統提供切實可行的策略，以加速醫療設備的採用，增強供應鏈的韌性，並在護理路徑中實現基於價值的臨床整合。

產業領導者應優先應對三大策略挑戰，以在不斷發展的心臟輔助設備市場中創造價值並降低風險。首先，投資於設備相容性和模組化架構，以實現功能升級並與監測生態系統整合。這種方法可以降低買方的生命週期成本，並支援差異化的升級路徑。其次，透過組件來源多元化、評估區域組裝或最終階段整合以及談判貿易附加條款來增強供應鏈韌性，從而抵禦關稅波動和物流中斷的影響。

我們進行穩健的混合方法研究，結合臨床醫生的見解、監管和技術審查以及供應鏈情境分析，得出可操作且檢驗的結論。

本調查方法採用混合方法，整合了定性專家訪談、器械技術評估、監管環境審查和供應鏈分析，以全面了解心臟輔助器械產業。研究透過對循環系統醫生、介入性心臟病專家、循環管理技師、採購經理和醫院高級管理人員進行結構化訪談，獲取關鍵訊息，以了解實際運作情況和推廣應用障礙。此外，研究還利用監管申報文件、已發表的臨床文獻和器械技術規範進行二次分析，以檢驗性能特徵並明確區分不同器械類別。

臨床創新、供應韌性和有針對性的商業化正在融合，形成關鍵趨勢的匯聚，從而實現先進心臟輔助技術的永續整合。

總之，心臟輔助設備及相關設備的市場格局呈現出創新加速、臨床模式轉變以及供應鏈和政策日益複雜的特徵。設備設計的不斷改進、微創植入方法的進步以及遠端監測技術的進步，為更廣泛的應用鋪平了道路；而關稅趨勢和區域監管差異則要求企業製定適應性強的商業和營運策略。設備類型、醫療環境、臨床應用和分銷管道之間的相互作用，需要進行精準的市場細分，以指導產品開發和市場進入策略的發展。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 心臟輔助裝置與設備市場：依產品類型分類

  • 導管式心室輔助系統
  • 體外膜氧合器
  • 主動脈內球囊反搏泵
  • 心室輔助裝置
    • 連續流
      • 雙心室輔助裝置
      • 左心室輔助裝置
      • 右心輔助裝置
    • 脈動流速

第9章：心臟輔助裝置與設備市場：依適應症分類

  • 雙心室衰竭
  • 左心臟衰竭
  • 右心臟衰竭

第10章：心臟輔助裝置及設備市場：依交付方式分類

  • 侵入性
  • 微創

第11章 心臟輔助設備市場：依最終使用者分類

  • 門診手術中心
  • 心臟中心
  • 醫院

第12章 心臟輔助裝置及設備市場：依應用領域分類

  • 彌合復甦差距
  • 彌合移植差距
  • 最終治療

第13章 心臟輔助設備市場：依通路分類

  • 直銷
  • 批發的

第14章 心臟輔助設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 心臟輔助裝置及設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 心臟輔助設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國心臟輔助裝置及設備市場

第18章：中國心臟輔助設備市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Abiomed, Inc.
  • Baxter International Inc.
  • Berlin Heart GmbH
  • BiVACOR Inc
  • Getinge AB
  • Jarvik Heart, Inc
  • LivaNova PLC
  • Medos Medizintechnik AG
  • Medtronic plc
  • Teleflex Incorporated
  • Terumo Corporation
Product Code: MRR-2B5802CFEB47

The Cardiac Assist Devices & Equipment Market was valued at USD 1.94 billion in 2025 and is projected to grow to USD 2.08 billion in 2026, with a CAGR of 7.96%, reaching USD 3.32 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.94 billion
Estimated Year [2026] USD 2.08 billion
Forecast Year [2032] USD 3.32 billion
CAGR (%) 7.96%

Framing the strategic significance of cardiac assist devices amid clinical evolution and operational pressures across acute and chronic cardiovascular care pathways

The opening synopsis establishes the scope and critical importance of cardiac assist devices and allied equipment in modern cardiovascular care. Over the past decade, technological advances, changing clinical pathways, and evolving patient demographics have placed devices such as ventricular assist systems, intra-aortic balloon pumps, catheter-based ventricular support systems, and extracorporeal membrane oxygenation at the center of life-sustaining therapies. Clinicians and health system leaders now regard these technologies not merely as rescue interventions but as integrated components of care pathways that span acute stabilization, bridge strategies, and long-term circulatory support.

Consequently, stakeholders ranging from hospital procurement teams to specialized cardiac centers are wrestling with decisions that require balancing clinical efficacy, procedural complexity, reimbursement considerations, and capital planning. As the ecosystem matures, collaboration between device manufacturers, service providers, clinicians, and payers becomes increasingly vital. The introductory framing emphasizes how device modularity, procedural innovation, and patient-centered design are reshaping both inpatient workflows and post-procedure management, thereby redefining expectations for device performance and vendor partnerships.

Ultimately, the introduction positions the reader to appreciate subsequent sections that examine transformative shifts, policy impacts, segmentation dynamics, and regional nuances that collectively inform strategic decision making across the cardiac assist device landscape.

How innovation in device design, minimally invasive delivery, digital telemetry, and hybrid care pathways is reshaping clinician practice and vendor differentiation

The landscape for cardiac assist devices is undergoing transformative shifts driven by innovation in device architecture, procedural approaches, and clinical evidence generation. Continuous-flow ventricular assist devices have moved from niche rescue tools to increasingly durable options for destination therapy, while catheter-based ventricular support systems are enabling shorter procedural times and broader applicability in high-risk percutaneous interventions. These technological trajectories are complemented by advances in extracorporeal membrane oxygenation that emphasize portability, oxygenator efficiency, and simplified anticoagulation strategies, thereby expanding indications and point-of-care deployment.

Meanwhile, the rhythm of adoption is influenced by improvements in minimally invasive delivery modes and hybrid procedural models that combine percutaneous and surgical techniques. As a result, delivery models and clinical teams must adapt, incorporating cross-disciplinary training and reconfigured care pathways to support post-procedural monitoring, infection control, and remote patient management. In parallel, manufacturers are increasingly integrating digital telemetry and remote monitoring capabilities to support earlier discharge and longitudinal follow-up, which in turn pressures service models and reimbursement frameworks to evolve.

Consequently, these converging trends create opportunities for market entrants and incumbents to differentiate through device interoperability, lifecycle services, and evidence generation that demonstrates real-world outcomes. In short, the field is moving toward a more connected, patient-centric paradigm that emphasizes procedural efficiency, long-term management, and value-based performance.

Navigating the downstream effects of evolving tariff policies through supply chain resilience, localization, and procurement risk mitigation strategies

The cumulative effects of tariff policy shifts and trade measures enacted through 2025 have introduced new considerations for manufacturers, distributors, and health systems that rely on cross-border supply chains for cardiac assist devices and consumables. Tariff-related cost pressures have accentuated the importance of localized manufacturing, regional supply agreements, and inventory optimization strategies to mitigate variability in landed cost and procurement lead times. In this environment, procurement teams have had to reassess vendor sourcing, with an emphasis on supply continuity and contractual protections that address tariff volatility and customs-related delays.

Moreover, regulatory harmonization and documentation requirements tied to customs classifications have required closer coordination between regulatory affairs and commercial functions, as compliance missteps can compound tariff-related financial exposure. Consequently, some manufacturers have accelerated plans for regional assembly or selected component localization to preserve competitiveness while maintaining clinical performance standards. Other organizations have prioritized strategic stockpiling of critical components and sought long-term agreements with logistics partners capable of managing customs complexities and expedited cross-border movements.

In addition, the tariff landscape has implications for the rollout cadence of next-generation devices. Developers must factor in not only development timelines and clinical validation but also the economics of distribution under shifting trade regimes. Collectively, these responses underscore a broader shift toward resilient supply chain architectures that place equal weight on trade risk mitigation, regulatory conformity, and sustaining clinical access across diverse care settings.

How nuanced segmentation across product architectures, clinical applications, care settings, procedural approaches, and distribution routes informs differentiated commercial and clinical strategies

Segmentation analysis illuminates how product typologies, care settings, clinical applications, indications, delivery modes, and distribution channels uniquely shape technology adoption and service requirements across the value chain. Within product categories, devices range from catheter-based ventricular support systems that support short-term circulatory assistance during high-risk interventions to extracorporeal membrane oxygenation systems that serve as intensive support platforms. Intra-aortic balloon pumps remain a tactical adjunct for hemodynamic stabilization, while ventricular assist devices, split between continuous flow and pulsatile flow architectures, address a spectrum of chronic and acute circulatory failures. Continuous-flow platforms further fragment into devices intended for left, right, and biventricular support, each presenting distinct implantation complexity, follow-up needs, and clinical outcome profiles.

End-user segmentation highlights divergent procurement and operational priorities across ambulatory surgical centers, dedicated cardiac centers, and general hospitals. Ambulatory surgical centers emphasize throughput, minimally invasive delivery, and low-footprint solutions, whereas cardiac centers prioritize advanced device capabilities, specialized staff competencies, and research collaborations. Hospitals balance acute care readiness with capital planning and intensive care capacity.

Regarding application, therapies are deployed across bridge-to-recovery, bridge-to-transplant, and destination therapy contexts, and each application imposes different clinical monitoring, device durability, and patient selection considerations. Indication-based differentiation across biventricular failure, left heart failure, and right heart failure further complicates device selection and care pathways, since physiologic support requirements and complication profiles vary substantially. Delivery mode categorization into invasive and minimally invasive approaches shifts not only procedural staffing and training needs but also impacts perioperative pathway design. Lastly, distribution channels-direct sales versus distributor models-affect contractual relationships, service-level agreements, and the feasibility of integrated post-market services such as training, maintenance, and remote monitoring deployment.

Regional variations in regulatory regimes, clinical capacity, and reimbursement priorities that determine adoption pathways and commercialization tactics across global markets

Regional dynamics exert a strong influence on device design priorities, regulatory pathways, and commercial deployment strategies. Across the Americas, the emphasis rests on integration with tertiary care networks, robust reimbursement frameworks for advanced therapies, and an appetite for outcomes-driven evidence that supports long-term device adoption. In this region, centers of excellence and high-volume tertiary hospitals play a central role in establishing clinical protocols and training models that ripple outward to smaller hospitals and specialized cardiac centers.

In Europe, the Middle East & Africa, the regulatory environment and heterogeneous payer systems shape adoption timelines and the types of devices prioritized, with an emphasis on interoperability, compliance with regional device directives, and flexible service models that can accommodate diverse health system capacities. In addition, pockets of advanced cardiac care coexist with underserved regions, prompting manufacturers to tailor device portfolios across cost, complexity, and support offerings. Partnerships with regional distributors and clinical training organizations are therefore critical to scale adoption.

Asia-Pacific presents a varied landscape characterized by rapid infrastructure investment, growing clinical capacity for advanced cardiac interventions, and a rising focus on minimally invasive and portable solutions that serve both urban centers and expanding regional hospitals. Furthermore, local manufacturing initiatives and policies supporting domestic medical technology industries influence strategic choices for multinational suppliers, while demographic trends drive demand for chronic circulatory support and post-acute care innovations.

Competitive dynamics defined by modular technological platforms, integrated service models, and clinical partnerships that accelerate adoption and long-term device utilization

Competitive dynamics in the cardiac assist device domain are shaped by a combination of technological differentiation, lifecycle service offerings, and strategic partnerships with clinical institutions. Leading manufacturers are investing in modular platforms that facilitate upgrades and interoperability with monitoring ecosystems, while new entrants focus on niche value propositions such as device portability, simplified anticoagulation profiles, or service-centric business models that bundle technology with training and remote support.

Collaborations between device makers and digital health providers are accelerating the integration of telemetry and predictive analytics, which enhances post-implant surveillance and supports remote care pathways. Simultaneously, contract and service models are evolving to include outcomes-based components and extended maintenance agreements, reflecting buyer preferences for predictable total cost of ownership and clinical performance guarantees.

From a commercialization perspective, companies that can align clinical evidence generation with targeted reimbursement strategies and scalable training programs are positioned to capture sustainable adoption across complex hospital networks and specialized cardiac centers. Strategic M&A, licensing arrangements for components or software, and partnerships with regional distributors remain prominent routes to expand footprint while managing regulatory and logistical complexities.

Actionable strategies for manufacturers and health systems to drive device adoption, supply resilience, and value-based clinical integration across care pathways

Industry leaders should prioritize a three-fold strategic agenda to capture value and mitigate risk in an evolving cardiac assist devices environment. First, invest in device compatibility and modular architectures that allow feature upgrades and integration with monitoring ecosystems; this approach reduces lifecycle costs for buyers and supports differentiated upgrade pathways. Second, strengthen supply chain resilience by diversifying component sourcing, evaluating regional assembly or final-stage integration, and negotiating trade-contingent contractual terms that protect against tariff volatility and logistical disruptions.

Third, align commercial and clinical strategies by investing in evidence generation that speaks to real-world outcomes across bridge-to-recovery, bridge-to-transplant, and destination therapy cohorts; simultaneously, develop service offerings that include structured training, remote monitoring, and maintenance agreements to reduce clinician burden and improve device uptime. In parallel, adopt flexible distribution strategies that balance direct sales where clinical complexity demands close vendor involvement with selective distributor partnerships for broader reach in fragmented markets.

Finally, cultivate partnerships with health systems and payers to pilot value-based contracting models and supply utilization programs. By doing so, leaders can demonstrate economic case studies that complement clinical evidence and expedite the integration of advanced support devices into standard care pathways.

Robust mixed-methods research combining clinician insights, regulatory and technical reviews, and supply chain scenario analysis to derive actionable and validated conclusions

The research methodology combines a mixed-methods approach that integrates qualitative expert interviews, device technology assessments, regulatory landscape reviews, and supply chain analysis to form a holistic view of the cardiac assist device space. Primary inputs include structured interviews with cardiovascular surgeons, interventional cardiologists, perfusionists, procurement leaders, and senior hospital administrators to capture operational realities and adoption barriers. Secondary analysis draws on regulatory filings, published clinical literature, and device technical specifications to validate performance characteristics and differentiate device classes.

To ensure rigor, findings are triangulated across multiple data streams and cross-checked with clinician feedback on real-world usability, training needs, and complication management. Supply chain assessment employs scenario analysis to evaluate the implications of trade policy shifts, logistics constraints, and component concentration risks. Competitive mapping synthesizes public company disclosures, product portfolios, and partnership announcements to depict strategic positioning without relying on proprietary or restricted data.

Throughout the methodology, care is taken to preserve confidentiality of interviewees and to present aggregated insights that reflect sector-wide trends rather than identifiable commercial metrics. This approach ensures that recommendations are actionable, clinically grounded, and sensitive to the operational constraints faced by health systems and device suppliers.

Synthesis of key trends showing how clinical innovation, supply resilience, and targeted commercialization together enable sustainable integration of advanced cardiac support technologies

In conclusion, the cardiac assist devices and equipment landscape is characterized by accelerating innovation, shifting clinical paradigms, and heightened supply chain and policy complexity. Continuous improvements in device design, minimally invasive delivery, and remote monitoring create pathways for broader adoption, while tariff dynamics and regional regulatory variability necessitate adaptive commercial and operational strategies. The interplay of device typology, care setting, clinical application, and distribution approach requires nuanced segmentation to inform product development and go-to-market decisions.

Collectively, manufacturers and health systems that embrace modular design, prioritize evidence aligned with specific indications and applications, and invest in resilient supply and service models will be better positioned to meet clinician expectations and patient needs. As the ecosystem continues to evolve, collaboration across clinical, commercial, and regulatory functions will be essential to translate technological advances into improved outcomes and sustainable care models. In short, the field is ripe for strategic action that harmonizes clinical efficacy with pragmatic operational planning.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cardiac Assist Devices & Equipment Market, by Product Type

  • 8.1. Catheter-Based Ventricular Support System
  • 8.2. Extracorporeal Membrane Oxygenation
  • 8.3. Intra-Aortic Balloon Pump
  • 8.4. Ventricular Assist Device
    • 8.4.1. Continuous Flow
      • 8.4.1.1. Biventricular Assist Device
      • 8.4.1.2. Left Ventricular Assist Device
      • 8.4.1.3. Right Ventricular Assist Device
    • 8.4.2. Pulsatile Flow

9. Cardiac Assist Devices & Equipment Market, by Indication

  • 9.1. Biventricular Failure
  • 9.2. Left Heart Failure
  • 9.3. Right Heart Failure

10. Cardiac Assist Devices & Equipment Market, by Delivery Mode

  • 10.1. Invasive
  • 10.2. Minimally Invasive

11. Cardiac Assist Devices & Equipment Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Cardiac Centers
  • 11.3. Hospitals

12. Cardiac Assist Devices & Equipment Market, by Application

  • 12.1. Bridge To Recovery
  • 12.2. Bridge To Transplant
  • 12.3. Destination Therapy

13. Cardiac Assist Devices & Equipment Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. Distributor Sales

14. Cardiac Assist Devices & Equipment Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Cardiac Assist Devices & Equipment Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Cardiac Assist Devices & Equipment Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Cardiac Assist Devices & Equipment Market

18. China Cardiac Assist Devices & Equipment Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. Abiomed, Inc.
  • 19.7. Baxter International Inc.
  • 19.8. Berlin Heart GmbH
  • 19.9. BiVACOR Inc
  • 19.10. Getinge AB
  • 19.11. Jarvik Heart, Inc
  • 19.12. LivaNova PLC
  • 19.13. Medos Medizintechnik AG
  • 19.14. Medtronic plc
  • 19.15. Teleflex Incorporated
  • 19.16. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CATHETER-BASED VENTRICULAR SUPPORT SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CATHETER-BASED VENTRICULAR SUPPORT SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CATHETER-BASED VENTRICULAR SUPPORT SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INTRA-AORTIC BALLOON PUMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INTRA-AORTIC BALLOON PUMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INTRA-AORTIC BALLOON PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PULSATILE FLOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PULSATILE FLOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PULSATILE FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY BIVENTRICULAR FAILURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY BIVENTRICULAR FAILURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY BIVENTRICULAR FAILURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY LEFT HEART FAILURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY LEFT HEART FAILURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY LEFT HEART FAILURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY RIGHT HEART FAILURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY RIGHT HEART FAILURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY RIGHT HEART FAILURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CARDIAC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CARDIAC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY BRIDGE TO RECOVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY BRIDGE TO RECOVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY BRIDGE TO RECOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DESTINATION THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DESTINATION THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DESTINATION THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. GCC CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. GCC CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. GCC CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 162. GCC CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 163. GCC CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 164. GCC CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 165. GCC CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. GCC CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. GCC CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPEAN UNION CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPEAN UNION CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPEAN UNION CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. BRICS CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 180. BRICS CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 181. BRICS CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 182. BRICS CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 186. G7 CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. G7 CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. G7 CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 189. G7 CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 190. G7 CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 191. G7 CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 192. G7 CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. G7 CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. G7 CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 195. NATO CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. NATO CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. NATO CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 198. NATO CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 199. NATO CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 200. NATO CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 201. NATO CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. NATO CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. NATO CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 204. GLOBAL CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED STATES CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED STATES CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. UNITED STATES CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED STATES CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED STATES CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED STATES CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 214. CHINA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 215. CHINA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. CHINA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 218. CHINA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 219. CHINA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA CARDIAC ASSIST DEVICES & EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)